Nothing Special   »   [go: up one dir, main page]

STAT

Opinion: 3 tips for successful global pharma collaboration and licensing agreements

Global partnerships are becoming the lifeblood of large #pharma companies and small #biotech startups. Here's how to make them a success.

Partnerships have long been the lifeblood of both large pharmaceutical companies and small biotech startups. Today, small biotech companies increasingly have the upper hand, as innovative technologies disrupt the competitor landscape and rich capital markets have lessened the necessity for deal-making.

These factors give biotech companies more choices in how to fund their research and development as well as how they commercialize new products. They also provide enhanced leverage in selecting partners and negotiating contract details. As a result, transformational global collaborations across the industry

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders And Novo Nordisk CEO Sparring, Roche Refocusing, And More
U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.
STAT1 min read
STAT+: Pharmalittle: We’re Reading About Chinese Drugmakers Weighing Sales, Medicare Price Talks, And More
Chinese drugmakers targeted by forthcoming U.S. national security legislation are working on sales of some operations
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Compounders Suing The FDA, Biogen Turning To Telehealth, And More
A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes and obesity drug from a shortages list

Related Books & Audiobooks